IITRI Joins National Chemical & Biological Defense Consortium
IITRI is pleased to announce our acceptance as a member into the National Chemical & Biological Defense Consortium (NCBDC).
The mission of the Consortium will be to provide the US Department of Defense with innovative solutions to counter biological and chemical and threats. IITRI’s extensive experience in infectious disease and biodefense, capabilities for preclinical evaluation of potential therapeutics, and biosafety level 2 and 3 facilities will be a valuable resource to the Consortium.
More information about the NCBDC can be found here.
Contact us for more information about animal models for infectious disease or our bioaerosol capabilities.